Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples

Testing for high-risk human papillomavirus (HPV) as part of primary cervical cancer screening has become more common recently. The Cobas 6800, an FDA-approved cervical screening platform, detects 14 high-risk HPVs, including HPV16 and HPV18. However, this test is limited to only women, which leads t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajjar, Brian Joseph, Raheel, Ummar, Manina, Rachel, Simpson, Jovanie, Irfan, Muhammad, Waheed, Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305403/
https://www.ncbi.nlm.nih.gov/pubmed/37376460
http://dx.doi.org/10.3390/vaccines11061071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305403/
https://www.ncbi.nlm.nih.gov/pubmed/37376460
http://dx.doi.org/10.3390/vaccines11061071

Ejemplares similares